DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE : Impact Factor & More
eISSN: 1179-9900pISSN: 1179-9900
Share this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE Journal Specifications
Indexed in the following public directories
Web of Science
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program.
- 1 Apr 2026
- Degenerative neurological and neuromuscular disease
Agreement and Comparative Performance of Cognitive Testing, Visual MRI Rating, and Automated Brain Morphometry in Older Adults with Suspected Dementia in Uganda.
- 1 Apr 2026
- Degenerative neurological and neuromuscular disease
Advancements in Therapy for Alzheimer’s Disease Based on the Cerebral Lymphatic System
- 31 Jan 2026
- Degenerative Neurological and Neuromuscular Disease
The Gut-Brain Axis in Alzheimer's: From Microbiota Genetics to Stigmasterol's Neuroprotection Mechanism.
- 1 Jan 2026
- Degenerative neurological and neuromuscular disease
Emodin, a Phytotherapeutic Anthraquinone, Potently Attenuates Synaptic Redox Pathology in Aged Rats.
- 1 Jan 2026
- Degenerative neurological and neuromuscular disease
Genetic Spectrum and Phenotypic Variability in Chinese Patients with Multisystem Proteinopathy and Related Disorders.
- 1 Jan 2026
- Degenerative neurological and neuromuscular disease
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program.
- 1 Apr 2026
- Degenerative neurological and neuromuscular disease
Agreement and Comparative Performance of Cognitive Testing, Visual MRI Rating, and Automated Brain Morphometry in Older Adults with Suspected Dementia in Uganda.
- 1 Apr 2026
- Degenerative neurological and neuromuscular disease
Advancements in Therapy for Alzheimer’s Disease Based on the Cerebral Lymphatic System
- 31 Jan 2026
- Degenerative Neurological and Neuromuscular Disease
The Gut-Brain Axis in Alzheimer's: From Microbiota Genetics to Stigmasterol's Neuroprotection Mechanism.
- 1 Jan 2026
- Degenerative neurological and neuromuscular disease
Emodin, a Phytotherapeutic Anthraquinone, Potently Attenuates Synaptic Redox Pathology in Aged Rats.
- 1 Jan 2026
- Degenerative neurological and neuromuscular disease
Genetic Spectrum and Phenotypic Variability in Chinese Patients with Multisystem Proteinopathy and Related Disorders.
- 1 Jan 2026
- Degenerative neurological and neuromuscular disease
FAQs on DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE
How long has DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE been actively publishing? 
What is the publishing frequency of DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE?
How many articles did DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE publish last year?
What is the eISSN & pISSN for DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE?
Who is the publisher of DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE?
